Nexalis Therapeutics Ltd

NEW
ASX:NX1 (Australia)  
A$ 0.011 (0%) Jul 22
At Loss
Market Cap:
A$ 2.78M ($ 1.95M)
Enterprise V:
A$ 3.09M ($ 2.17M)
Volume:
0
Avg Vol (2M):
489.95K
Trade In:

Nexalis Therapeutics Ltd (ASX:NX1) Dividend

Nexalis Therapeutics Ltd (ASX:NX1) does not currently pay a regular dividend. Over the past 3 years it has returned capital to shareholders via buybacks at a rate of -8.3%. View its historical dividend record below and compare with dividend-paying peers.

Frequently Asked Questions: ASX:NX1 Dividend

Does Nexalis Therapeutics Ltd (ASX:NX1) pay a dividend?

Nexalis Therapeutics Ltd (ASX:NX1) does not currently pay a regular dividend. Review the historical record above for any past dividend payments or capital return policies.

Why doesn't Nexalis Therapeutics Ltd pay a dividend?

Companies typically forgo dividends to reinvest earnings into growth, R&D, acquisitions, or share buybacks. Nexalis Therapeutics Ltd has returned capital to shareholders via buybacks at a rate of -8.3% over the past 3 years.

What are dividend-paying alternatives to Nexalis Therapeutics Ltd?

For dividend-paying alternatives in Nexalis Therapeutics Ltd's sector, view dividend stocks by industry on GuruFocus's dividend stock screener.